跳至主要内容
临床试验/NCT03614598
NCT03614598已完成不适用

Impact on Postoperative Pain of Three Single-use Adult Supraglottic Airway Devices in Short General Anesthetic Under Controlled Ventilation

Centre Hospitalier Universitaire de Nīmes2 个研究点 分布在 1 个国家目标入组 546 人开始时间: 2009年4月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
546
试验地点
2
主要终点
Incidence of pharyngolaryngeal postoperative pain of the three devices

研究概览

简要总结

The investigators hypothesize that incidence of pharyngolaryngeal postoperative pain caused by the I-gel and LMA-Suprême devices will be ≤ 5%

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The patient must have given their free and informed consent and signed the consent form
  • •The patient must be a member or beneficiary of a health insurance plan
  • •Adult patients > 18
  • •ASA score I-III
  • •Patient scheduled to undergo elective surgery lasting less than two hours under general anaesthetic without tracheal intubation
  • •The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
  • •The subject refuses to sign the consent
  • •It is impossible to give the subject informed information
  • •The patient is under safeguard of justice or state guardianship
  • •The patient is pregnant or breastfeeding
  • •Emergency surgery
  • •Sore thoat ≤ 1 month
  • •Risk of aspiration of gastric contents
  • •Body mass index (BMI) > 35
  • •Patients with expected airway difficulties
  • •Contra-indication for any of the devices (symptomatic hiatal hernias, pathological obesity, poly trauma or serious injury, delayed gastric emptying, use of opiates during fasting)
  • •Patients who are not fasting for routine and emergency anesthesia
  • •Trismus, limited mouth opening, abscess or pharyngoperilaryngeal mass

排除标准

  • 未提供

研究组 & 干预措施

I-GEL®

Active Comparator

干预措施: Insertion of I-GEL(R) device (Procedure)

LMA-UNIQUE™

Active Comparator

干预措施: Insertion of LMA-UNIQUE(TM) device (Procedure)

LMA-SUPREME™

Active Comparator

干预措施: Insertion of LMA-SUPREME(TM) device (Procedure)

结局指标

主要结局

Incidence of pharyngolaryngeal postoperative pain of the three devices

时间窗: 24 hours

Sore throat Y/N

次要结局

  • Time taken to place device(End of surgery (maximum 2 hours))
  • Necessity of altering the size of the device(End of surgery (maximum 2 hours))
  • Total leakage pressure of the devices(End of surgery (maximum 2 hours))
  • Device stability during surgery(End of surgery (maximum 2 hours))
  • Any patient movement during procedure(End of surgery (maximum 2 hours))
  • Ventilatory pressure of the devices(End of surgery (maximum 2 hours))
  • Pharyngolaryngeal postoperative pain between groups(2 hours)
  • Number of attempts needed to place device(End of surgery (maximum 2 hours))
  • Difficulty of insertion(End of surgery (maximum 2 hours))
  • Difficulty of device removal(End of surgery (maximum 2 hours))

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验